FIDELIO-DKD
Phase III study
Phase III FIDELIO-DKD study in patients with chronic kidney disease and type 2 diabetes
The finenerone phase III clinical trial programme comprises the FIDELIO-DKD and FIGARO-DKD studies, and is the largest of its kind to date
Overview of the FIDELIO-DKD and FIGARO-DKD phase III studies of finerenone in patients with chronic kidney disease and type 2 diabetes7,8
